Millennium Management
PBLA

Millennium Management’s Panbela Therapeutics, Inc. Common Stock PBLA Stock Holding History

Millennium Management’s Portfolio PBLA Stock Details PBLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1
Closed -$72K – 7701
2021
Q3 		$72K Buy
+1
New +$58.5K ﹤0.01% 6521
2021
Q1 		– Hold
0
– -$41K – 6706
2020
Q4 		– Hold
0
– – – 5098

Other funds holding PBLA

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
FPS
Fieldpoint Private Securities Greenwich, Connecticut $344M AUM 7.21% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BSW
Buckingham Strategic Wealth Clayton, Missouri $9.66B AUM 15.76% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management's PBLA Position: Q4 2021 in Review

Millennium Management sold out of Panbela Therapeutics, Inc. Common Stock (PBLA) in Q4 2021, closing a stake of 1 share — an estimated $72K sold.

Millennium Management first reported a position in PBLA in Q3 2021 and held it in 1 quarter. The position peaked at $72K in Q3 2021. 10 funds tracked by Wall St. Rank hold PBLA as of Q4 2021.

  • Millennium Management reported no remaining Panbela Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Millennium Management sold 1 Panbela Therapeutics, Inc. Common Stock share in Q4 2021, an estimated $72K.
  • Millennium Management first reported a position in Panbela Therapeutics, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Millennium Management's Panbela Therapeutics, Inc. Common Stock position peaked at $72K in Q3 2021.
  • 10 funds tracked by Wall St. Rank held Panbela Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Millennium Management's 13F filing for Q4 2021, filed 14 Feb 2022.